Expression of human FUS/TLS in yeast leads to protein aggregation and cytotoxicity, recapitulating key features of FUS proteinopathy

Abstract

Mutations in the fused in sarcoma/translocated in liposarcoma (FUS/TLS) gene have been associated with amyotrophic lateral sclerosis (ALS). FUS-positive neuropathology is reported in a range of neurodegenerative diseases, including ALS and fronto-temporal lobar degeneration with ubiquitin-positive pathology (FTLD-U). To examine protein aggregation and cytotoxicity, we expressed human FUS protein in yeast. Expression of either wild type or ALS-associated R524S or P525L mutant FUS in yeast cells led to formation of aggregates and cytotoxicity, with the two ALS mutants showing increased cytotoxicity. Therefore, yeast cells expressing human FUS protein recapitulate key features of FUS-positive neurodegenerative diseases. Interestingly, a significant fraction of FUS expressing yeast cells stained by propidium iodide were without detectable protein aggregates, suggesting that membrane impairment and cellular damage caused by FUS expression may occur before protein aggregates become microscopically detectable and that aggregate formation might protect cells from FUS-mediated cytotoxicity. The N-terminus of FUS, containing the QGSY and G rich regions, is sufficient for the formation of aggregates but not cytotoxicity. The C-terminal domain, which contains a cluster of mutations, did not show aggregation or cytotoxicity. Similar to TDP-43 when expressed in yeast, FUS protein has the intrinsic property of forming aggregates in the absence of other human proteins. On the other hand, the aggregates formed by FUS are thioflavin T-positive and resistant to 0.5% sarkosyl, unlike TDP-43 when expressed in yeast cells. Furthermore, TDP-43 and FUS display distinct domain requirements in aggregate formation and cytotoxicity.

Keywords

FUS/TLS / protein aggregation / cytotoxicity

References

[1] Alberti, S., Halfmann, R., King, O., Kapila, A., and Lindquist, S. (2009). A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell 137, 146-158 .19345193
[2] Bagriantsev, S.N., Kushnirov, V.V., and Liebman, S.W. (2006). Analysis of amyloid aggregates using agarose gel electrophoresis. Methods Enzymol 412, 33-48 .17046650
[3] Bosco, D.A., Lemay, N., Ko, H.K., Zhou, H., Burke, C., Kwiatkowski, T.J. Jr, Sapp, P., McKenna-Yasek, D., Brown, R.H. Jr, and Hayward, L.J. (2010). Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum Mol Genet 19, 4160-4175 .20699327
[4] Buratti, E., and Baralle, F.E. (2008). Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front Biosci 13, 867-878 .17981595
[5] Cushman, M., Johnson, B.S., King, O.D., Gitler, A.D., and Shorter, J. (2010). Prion-like disorders: blurring the divide between transmissibility and infectivity. J Cell Sci 123, 1191-1201 .20356930
[6] Derkatch, I.L., Bradley, M.E., Hong, J.Y., Liebman, S.W., Brown, R.H. Jr, and Hayward, L.J. (2001). Prions affect the appearance of other prions: the story of [PIN(+)]. [PIN(+)] Cell 106, 171-182 .11511345
[7] Dormann, D., Rodde, R., Edbauer, D., Bentmann, E., Fischer, I., Hruscha, A., Than, M.E., Mackenzie, I.R., Capell, A., Schmid, B., (2010). ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J 29, 2841-2857 .20606625
[8] Duennwald, M.L., Jagadish, S., Giorgini, F., Muchowski, P.J., and Lindquist, S. (2006). A network of protein interactions determines polyglutamine toxicity. Proc Natl Acad Sci U S A 103, 11051-11056 .16832049
[9] Gal, J., Zhang, J., Kwinter, D.M., Zhai, J., Jia, H., Jia, J., and Zhu, H. (2010). Nuclear localization sequence of FUS and induction of stress granules by ALS mutants. Neurobiol Aging .
[10] Huang, E.J., Zhang, J., Geser, F., Trojanowski, J.Q., Strober, J.B., Dickson, D.W., Brown, R.H. Jr, Shapiro, B.E., and Lomen-Hoerth, C. (2010). Extensive FUS-Immunoreactive Pathology in Juvenile Amyotrophic Lateral Sclerosis with Basophilic Inclusions. Brain Pathol .
[11] Ito, D., Seki, M., Tsunoda, Y., Uchiyama, H., and Suzuki, N. (2010). Nuclear transport impairment of amyotrophic lateral sclerosis-linked mutations in FUS/TLS. Ann Neurol 8, 11.21154481
[12] Johnson, B.S., McCaffery, J.M., Lindquist, S., and Gitler, A.D. (2008). A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proc Natl Acad Sci U S A 105, 6439-6444 .18434538
[13] Johnson, B.S., Snead, D., Lee, J.J., McCaffery, J.M., Shorter, J., and Gitler, A.D. (2009). TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J Biol Chem 284, 20329-20339 .19465477
[14] Krobitsch, S., and Lindquist, S. (2000). Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc Natl Acad Sci U S A 97, 1589-1594 .10677504
[15] Kwiatkowski, T.J., Jr., Bosco, D.A., Leclerc, A.L., Tamrazian, E., Vanderburg, C.R., Russ, C., Davis, A., Gilchrist, J., Kasarskis, E.J., Munsat, T., (2009). Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science (New York, NY 323, 1205-1208 .
[16] Lagier-Tourenne, C., Polymenidou, M., and Cleveland, D.W. (2010). TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet 19, R46-R64 .20400460
[17] Li, Y., Ray, P., Rao, E.J., Shi, C., Guo, W., Chen, X., Woodruff, E.A. 3rd, Fushimi, K., and Wu, J.Y. (2010). A Drosophila model for TDP-43 proteinopathy. Proc Natl Acad Sci U S A 107, 3169-3174 .20133767
[18] Munoz, D.G., Neumann, M., Kusaka, H., Yokota, O., Ishihara, K., Terada, S., Kuroda, S., and Mackenzie, I.R. (2009). FUS pathology in basophilic inclusion body disease. Acta Neuropathol 118, 617-627 .19830439
[19] Neumann, M., Rademakers, R., Roeber, S., Baker, M., Kretzschmar, H.A., and Mackenzie, I.R. (2009). A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 132, 2922-2931 .19674978
[20] Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (New York, NY 314(5796): 130-133 .
[21] Osherovich, L.Z., and Weissman, J.S. (2001). Multiple Gln/Asn-rich prion domains confer susceptibility to induction of the yeast [PSI(+)] prion. Cell 106(2): 183-194 .
[22] Outeiro, T.F., and Lindquist, S. (2003). Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science 302(5651): 1772-1775 .
[23] Peters, T.W., and Huang, M. (2007). Protein aggregation and polyasparagine-mediated cellular toxicity in Saccharomyces cerevisiae. Prion 1(2): 144-153 .
[24] Rabbitts, T.H., Forster, A., Larson, R., and Nathan, P. (1993). Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat Genet 4, 175-180 .7503811
[25] Tank, E.M., Harris, D.A., Desai, A.A., and True, H.L. (2007). Prion protein repeat expansion results in increased aggregation and reveals phenotypic variability. Mol Cell Biol 27, 5445-5455 .17548473
[26] Urwin, H., Josephs, K.A., Rohrer, J.D., Mackenzie, I.R., Neumann, M., Authier, A., Seelaar, H., Van Swieten, J.C., Brown, J.M., Johannsen, P., and the FReJA Consortium. (2010). FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol 120, 33-41 .20490813
[27] Vance, C., Rogelj, B., Hortobágyi, T., De Vos, K.J., Nishimura, A.L., Sreedharan, J., Hu, X., Smith, B., Ruddy, D., Wright, P., (2009). Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 323, 1208-1211 .19251628
[28] Woulfe, J., Gray, D.A., and Mackenzie, I.R. (2010). FUS-immunoreactive intranuclear inclusions in neurodegenerative disease. Brain Pathol 20, 589-597 .19832837
[29] Zinszner, H., Sok, J., Immanuel, D., Yin, Y., and Ron, D. (1997). TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. J Cell Sci 110, 1741-1750 .9264461